Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Commercial
Commercial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biospace News
-
July 18, 2019
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part Of A Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data and Artificial Intelligence-Driven Approach to Treating Ovarian Cancer
Deals
Spring Bank Announces Research Agreement with The National Institute of Allergy and Infectious Diseases to Evaluate HBV Antisense Oligonucleotide Compounds
Commercial
Aurinia Announces Further Strengthening of the Senior Management Team
Biospace News
-
July 18, 2019
0
Deals
Bayer, Bristol-Myers Squibb and Ono Pharma Team on Colorectal Cancer
Biospace News
-
July 18, 2019
0
Commercial
BioArctic and Eisai Present New Data Regarding BAN2401 at the Alzheimer’s...
Biospace News
-
July 18, 2019
0
Commercial
Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals
Biospace News
-
July 18, 2019
0
Merger
Emmaus Life Sciences Completes Merger
Biospace News
-
July 17, 2019
0
1
2
3
...
269
Page 1 of 269
- Advertisement -
MOST POPULAR
Homology Medicines Presents Preclinical Data from PKU Gene Therapy Program Demonstrating...
April 4, 2019
Alimera Sciences Announces Approval Received in the Mutual Recognition Procedure for...
March 25, 2019
Early-stage trial shows promising results for Opdivo, bempegaldesleukin combination in first-line...
February 15, 2019
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial...
February 12, 2019
Load more
HOT NEWS
Commercial
Gossamer Bio, After a Game of Government Shutdown Roulette, Wins Big...
Neurology
Allergan Announces Phase 3 Results for Rapastinel as an Adjunctive Treatment...
Deals
HitGen and SPARC Enter DNA-Encoded Library Based Innovative Drug Discovery Research...
Approval
Alimera Sciences Announces Approval for ILUVIEN in Kuwait
